NO985294L - Kontrastmidler - Google Patents

Kontrastmidler

Info

Publication number
NO985294L
NO985294L NO985294A NO985294A NO985294L NO 985294 L NO985294 L NO 985294L NO 985294 A NO985294 A NO 985294A NO 985294 A NO985294 A NO 985294A NO 985294 L NO985294 L NO 985294L
Authority
NO
Norway
Prior art keywords
group
integer
alkyl
contrast media
aryl
Prior art date
Application number
NO985294A
Other languages
English (en)
Other versions
NO985294D0 (no
Inventor
Jeffrey Long
Richard Holm
William Sanderson
Shi-Bao Yu
Zhiping Zheng
Original Assignee
Nycomed Salutar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Salutar Inc filed Critical Nycomed Salutar Inc
Publication of NO985294D0 publication Critical patent/NO985294D0/no
Publication of NO985294L publication Critical patent/NO985294L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0073—Rhodium compounds
    • C07F15/008—Rhodium compounds without a metal-carbon linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Forbindelser med formel (I) [M6Q6BnL6.nr hvor M er Re eller Rh; hver Q er et brodannende atom valgt fra O, S, Se og Te; B er et monovalent ikke-brodannende atom eller gruppe; L er en PR3-gruppe hvor R er C« alkyl eller aryl, eventuelt substituert på alkyl- eller arylgruppen med en eller flere vannsolubiliserende grupper så som en amin- eller hydroksygruppe eller de tre-R grupper danner sammen en C8.10 trivalent gruppe som også kan inneholde opptil tre nitrogen- eller oksygenatomer; n er et helt tall fra O til 6; og x er et helt tall fra -2 til +4, som representerer den totale ladningen til klusteret, og som når det ikke er null er sammen med en eller flere mot-ioner med lik og balanserende ladning, og kontrastmedier, spesielt røntgenkontrastmedier, inneholdende dem.
NO985294A 1996-05-14 1998-11-13 Kontrastmidler NO985294L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64900096A 1996-05-14 1996-05-14
US08/704,009 US5804161A (en) 1996-05-14 1996-08-26 Contrast agents
PCT/GB1997/001314 WO1997043293A1 (en) 1996-05-14 1997-05-14 Contrast agents

Publications (2)

Publication Number Publication Date
NO985294D0 NO985294D0 (no) 1998-11-13
NO985294L true NO985294L (no) 1999-01-13

Family

ID=27095513

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985294A NO985294L (no) 1996-05-14 1998-11-13 Kontrastmidler

Country Status (9)

Country Link
US (1) US5804161A (no)
EP (1) EP0901496A1 (no)
JP (1) JP2000510838A (no)
KR (1) KR20000011027A (no)
CN (1) CN1227562A (no)
AU (1) AU2784397A (no)
CA (1) CA2253307A1 (no)
NO (1) NO985294L (no)
WO (1) WO1997043293A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
US6524553B2 (en) * 1998-03-31 2003-02-25 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6537520B1 (en) 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
US6511649B1 (en) 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
US6569402B1 (en) * 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
JP2002532440A (ja) 1998-12-18 2002-10-02 デュポン ファーマシューティカルズ カンパニー ビトロネクチン受容体拮抗剤薬剤
WO2000035887A2 (en) 1998-12-18 2000-06-22 Du Pont Pharm Co Vitronectin receptor antagonist pharmaceuticals
US6794518B1 (en) 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US6656448B1 (en) * 2000-02-15 2003-12-02 Bristol-Myers Squibb Pharma Company Matrix metalloproteinase inhibitors
WO2001087354A2 (en) * 2000-05-17 2001-11-22 Bristol-Myers Squibb Pharma Company Use of small molecule radioligands for diagnostic imaging
NZ516746A (en) * 2000-06-01 2004-02-27 Bristol Myers Squibb Pharma Lactams substituted by cyclic succinates as inhibitors of A-beta protein production
WO2002036173A2 (en) 2000-11-03 2002-05-10 Bristol-Myers Squibb Pharma Company Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
US20090062256A1 (en) * 2001-06-01 2009-03-05 Bristol-Myers Squibb Pharma Company LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
WO2003013346A2 (en) * 2001-08-08 2003-02-20 Bristol-Myers Squibb Pharma Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
US6838074B2 (en) 2001-08-08 2005-01-04 Bristol-Myers Squibb Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
US20050106100A1 (en) * 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
US20050106101A1 (en) * 2003-10-31 2005-05-19 Ajay Purohit Novel chemical agents comprising an adenosine moiety or an adenosine analog moiety and an imaging moiety and methods of their use
US7485283B2 (en) 2004-04-28 2009-02-03 Lantheus Medical Imaging Contrast agents for myocardial perfusion imaging
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
US20060083681A1 (en) * 2004-10-18 2006-04-20 Ajay Purohit Compounds for myocardial perfusion imaging
US7858380B2 (en) * 2005-01-28 2010-12-28 Board Of Trustees Of Michigan State University Sol-gel encapsulated hexanuclear clusters for oxygen sensing by optical techniques
CA2613439A1 (en) * 2005-06-30 2007-01-11 Bristol-Myers Squibb Pharma Company Hydrazide conjugates as imaging agents
US7824659B2 (en) 2005-08-10 2010-11-02 Lantheus Medical Imaging, Inc. Methods of making radiolabeled tracers and precursors thereof
KR100820963B1 (ko) 2006-10-16 2008-04-11 엘지전자 주식회사 플라즈마 디스플레이 패널
CN101600728A (zh) 2006-12-04 2009-12-09 伊利诺斯大学理事会 使用铜氧还蛋白和富含CpG的DNA治疗癌症的组合物和方法
MX2009008508A (es) 2007-02-08 2010-04-21 Univ Illinois Composiciones y m?todos para prevenir el c?ncer con cupredoxinas.
DK2257315T3 (da) * 2008-02-29 2020-01-27 Lantheus Medical Imaging Inc Kontrastmidler til anvendelser omfattende perfusionsbilleddannelse
CN102458396B (zh) 2009-04-15 2017-05-10 兰休斯医疗成像公司 使用抗坏血酸稳定化放射性药物组合物
WO2011035140A1 (en) 2009-09-18 2011-03-24 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of contrast moieties to the lungs
TWI686370B (zh) 2010-02-08 2020-03-01 美商藍瑟斯醫學影像公司 用於合成造影劑及其中間體之方法及裝置
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
RU2624776C2 (ru) * 2015-10-28 2017-07-10 Федеральное государственное бюджетное учреждение науки Институт неорганической химии им. А.В. Николаева Сибирского отделения Российской академии наук Способ получения трис(2-карбоксиэтил)фосфиновых октаэдрических халькогенидных кластерных комплексов рения (варианты)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9006977D0 (en) * 1990-03-28 1990-05-23 Nycomed As Compositions

Also Published As

Publication number Publication date
CN1227562A (zh) 1999-09-01
JP2000510838A (ja) 2000-08-22
KR20000011027A (ko) 2000-02-25
EP0901496A1 (en) 1999-03-17
NO985294D0 (no) 1998-11-13
US5804161A (en) 1998-09-08
AU2784397A (en) 1997-12-05
CA2253307A1 (en) 1997-11-20
WO1997043293A1 (en) 1997-11-20

Similar Documents

Publication Publication Date Title
NO985294L (no) Kontrastmidler
MY107655A (en) Derivatives of benzofuran,benzothiophene,indole and indolizine,process for their preparation as well as the compositions containing them
ES8407025A1 (es) Un procedimiento para preparar derivados de nicotinamida.
EP0392376A3 (en) N-acyl derivatives of the ll-e33288 antitumor antibiotics
NZ292983A (en) Aminoheterocyclic derivatives, preparation and pharmaceutical compositions thereof
ZA916025B (en) Linker for bioactive agents
IL107551A0 (en) Novel compounds useful as sweetening agents and their method of preparation
UA37230C2 (uk) Полі-1-н-алкенаміни та склади палива або мастильного засобу, що їх містять
ES8405398A1 (es) Procedimiento para preparar nuevos diazabiciclo-(3.3.1)-nonanos
CA2040905A1 (en) Carbohydrate derivatives comprising a trisaccharide unit
ES445790A1 (es) Procedimiento para preparar derivados de 3-formilrifamicina sv.
ES8607980A1 (es) Procedimiento para la obtencion de muramilpeptidos
WO1996020185A3 (en) Tetrahydrofurans and tetrahydropyrans
TW324029B (en) De-oiling cleaner composition
ES8503354A1 (es) Un procedimiento de preparacion de nuevos derivados de carbapenem.
ES8702433A1 (es) Un procedimiento para la preparacion de un compuesto heterociclico sustituido con peptidos.
ES8401766A1 (es) Procedimiento para la preparacion de nuevas acinorrifamicinas.
PL341837A1 (en) Novel tricyclic compounds, method of obtaining them and pharmacological compositions containing such compounds
ES8403911A1 (es) Procedimiento de preparacion de mononitratos de 1.4,3.6- dianhidro-hexito sustituidos en 2-0 y 5-0
IT1283635B1 (it) Composti a scheletro camptotecinico isolati da mappia foetida e loro uso come sintoni per farmaci o come principi attivi
ES8200113A1 (es) Un procedimiento para la preparacion de derivados de cefalosporina.
RO85276A (ro) Procedeu pentru prepararea unor esteri tiazolidinici
ES8608477A1 (es) Procedimiento de preparar derivados de fenilalanina
ES475587A1 (es) Procedimiento para preparar derivados de isoquinolina
ES8603188A1 (es) Un procedimiento para la preparacion de compuestos de b -lactama

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application